[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556547":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":64,"collaborators":10,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":10,"studyType":79,"phases":10,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"ART Fertility Clinics LLC","OTHER",[8,12,17],{"label":9,"type":10,"description":11,"interventionNames":10},"Natural cycle",null,"Monitoring of a natural cycle",{"label":13,"type":10,"description":14,"interventionNames":15},"natural proliferative phase cycle","Monitoring of a natural proliferative phase cycle",[16],"Drug: Exposure to progesterone or HRT medication",{"label":18,"type":10,"description":19,"interventionNames":20},"Hormonal replacement cycle","Monitoring of a hormonal replacement cycle",[16],[22],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"DRUG","Exposure to progesterone or HRT medication","to add either progesterone only in the NPP protocol or E2 and progesterone in a HRT protocol",[18,13],[28],{"name":29,"affiliation":30,"role":31},"Barbara Lawrenz, PhD","ART Fertility Clinic","PRINCIPAL_INVESTIGATOR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Barbara Lawrenz, M.D. PhD","CONTACT","800 337845489","barbara.lawrenz@artfertilityclinics.com",{"name":39,"role":35,"phone":36,"phoneExt":10,"email":40},"Jonalyn Edades, MBA","jonalyn.edades@artfertilityclinics.com",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"ART Fertiltiy Clinic","RECRUITING","Abu Dhabi","Abu Dhabi Emirate","60202","United Arab Emirates","AE",{"type":51,"coordinates":52},"Point",[53,54],54.39696,24.45118,{"lat":54,"lon":53},[57,60,63],{"name":58,"role":35,"phone":59,"phoneExt":10,"email":37},"Barbara Lawrenz","00971526500757",{"name":39,"role":35,"phone":10,"phoneExt":61,"email":62},"Lawrenz","barbara.lawrenz@web.de",{"name":29,"role":31,"phone":10,"phoneExt":10,"email":10},{"type":65,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100556547","relaxin-measurement-in-different-endometrial-preparation-approaches-for-frozen-embryo-transfer-100556547",false,"NCT06526520","Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer","Inclusion Criteria:\n\n* regular menstrual cycles\n\nExclusion Criteria:\n\n* abnormal findings of the ovaries (e.g endometriosis)\n* Intake of any hormones within 3 months of study start\n* desire to become pregnant",true,"FEMALE","18 Years","35 Years",{"count":77,"type":78},5,"ESTIMATED","OBSERVATIONAL","To investigate the levels of Relaxin in different types of endometrial preparation for a frozen embryo transfer cycle. Up to now it is unclear, whether ovulation with a functional corpus luteum (CL) will be present in a natural proliferative phase (NPP) endometrial preparation approach.",[82],"Frozen Embryo Transfer",[84,85,86,87],"frozen embryo transfer","hormonal replacement cycle","natural cycle","Relaxin","2026-05-06",{"date":90,"type":91},"2026-05-11","ACTUAL",{"date":93,"type":91},"2024-08-01",{"date":95,"type":78},"2026-12-31",{"name":5,"class":6},1]